For patients who already have established atherosclerotic disease a prior heart attack, ischaemic stroke, or symptomatic peripheral arterial disease and who carry excess weight, the case for adding semaglutide to secondary prevention is now established. The European and American diabetes guidelines already say so in type 2 diabetes. SELECT pushes the same logic into patients without diabetes. The JACC meta-analysis suggests the benefit travels: with or without diabetes, with or without obesity, with or without chronic kidney disease. A few things the data do not yet say
5 Insulin degludec plus liraglutide (IDegLira) has been approved for type 2 diabetes mellitus
You can easily get started without stepping into a clinic, making it a great option for those with busy schedules
Currently, numerous treatment modalities for RB exist, including intravenous and arterial chemotherapy, external radiation, cryotherapy, and enucleation [308]
EADV Congress 2024, 25-38 September, 2024.
They mimic the action of the naturally occurring hormone GLP-1, which is involved in regulating blood sugar levels